A study on bladder cancer indicates that Parkin influences bladder cancer progression and metastasis by regulating cellular ROS levels through ubiquitin-mediated proteasomal degradation of Catalase, rather than its autophagic function. Here, PRKN is linked to urinary bladder carcinoma.